Strand, V., Smolen, J. S., van Vollenhoven, R. F., Mease, P., Burmester, G. R., Hiepe, F., . . . Schiff, M. (2011). Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: Analysis of patient-reported outcomes from the RAPID 2 trial. BMJ Group.
استشهاد بنمط شيكاغوStrand, Vibeke, et al. Certolizumab Pegol Plus Methotrexate Provides Broad Relief From the Burden of Rheumatoid Arthritis: Analysis of Patient-reported Outcomes From the RAPID 2 Trial. BMJ Group, 2011.
MLA استشهادStrand, Vibeke, et al. Certolizumab Pegol Plus Methotrexate Provides Broad Relief From the Burden of Rheumatoid Arthritis: Analysis of Patient-reported Outcomes From the RAPID 2 Trial. BMJ Group, 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.